Literature DB >> 25224651

Reversion of trichostatin A resistance via inhibition of the Wnt signaling pathway in human pancreatic cancer cells.

Benquan Wang1, Qian Zou1, Meng Sun1, Jingfeng Chen1, Tianyang Wang1, Yongheng Bai1, Zongjing Chen1, Bicheng Chen1, Mengtao Zhou1.   

Abstract

Drug resistance is a major impediment to successful chemotherapy in pancreatic cancer (PC) patients. We investigated the effect of Wnt/β-catenin signaling inhibition by wnt-c59 on chemoresistance in a trichostatin A-resistant Panc-1 cell line (Panc-1/TSA). Panc-1/TSA cells were treated with the Wnt/β‑catenin signaling inhibitor wnt-c59 (10 µmol · l-1) and/or trichostatin A (TSA; 10 µmol · l-1) for 24 h. CCK-8 assay was utilized to analyze the interactive effect of TSA and wnt-c59 on induction of apoptosis of the Panc-1/TSA cells. Cell apoptosis was measured by flow cytometry. Real-time PCR and western blotting were used to assess Wnt/β-catenin signaling, epithelial-mesenchymal transition (EMT) and multidrug resistance (MDR). Real-time cell analysis (RTCA) was used to detect the cell migration ability. After wnt-c59 treatment for 24 h, relative genes and transcriptional targets of Wnt/β-catenin signaling were downregulated (P<0.05). CCK-8 assay indicated that the combination of TSA and wnt-c59 had a synergistic effect on induction of Panc-1/TSA cell apoptosis. As detected by FACS, cell apoptosis rates increased significantly (P<0.05). The results of RTCA showed that the cell indices of the control group, wnt-c59 group, TSA group and TSA+wnt-c59 combination group were 1.2842±0.0257, 1.2155±0.0282, 1.2533±0.0194 and 0.8541±0.0250, respectively. In accordance, MMP-9 protein in the wnt-c59 treatment groups was decreased compared to the non-wnt-c59 treatment groups. Meanwhile, E-cadherin protein was upregulated and vimentin protein was downregulated, both of which are characteristic markers of EMT. Chemoresistant gene MDR1 and P-glycoprotein (P-gp) in the wnt-c59 treatment groups had a reduced expression compared to the non-wnt-c59 treatment groups. This study revealed that TSA sensitivity, migration ability, and the EMT phenotype in Panc-1/TSA cells were reversed following Wnt/β-catenin signaling inhibition.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25224651     DOI: 10.3892/or.2014.3476

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  7 in total

Review 1.  Unfolding antifungals: as a new foe to pancreatic ductal adenocarcinoma-a mini-review.

Authors:  Shruti Gupta; Atul Kumar; Kiran Kumar Tejavath
Journal:  Mol Biol Rep       Date:  2021-04-01       Impact factor: 2.316

2.  Rab11a sustains GSK3β/Wnt/β-catenin signaling to enhance cancer progression in pancreatic cancer.

Authors:  Li Yu; Xin Li; Haibin Li; Huixin Chen; Hua Liu
Journal:  Tumour Biol       Date:  2016-08-01

3.  Expression of Rab5a correlates with tumor progression in pancreatic carcinoma.

Authors:  Yuandong Li; Xiaofang Sun; Donghui Ji; Xiangshun Kong; Dengxiang Liu; Zhenya Zhao; Jingbo Yan; Shubo Chen
Journal:  Virchows Arch       Date:  2017-02-27       Impact factor: 4.064

Review 4.  Wnt/β-Catenin Signaling: The Culprit in Pancreatic Carcinogenesis and Therapeutic Resistance.

Authors:  Monish Ram Makena; Himavanth Gatla; Dattesh Verlekar; Sahithi Sukhavasi; Manoj K Pandey; Kartick C Pramanik
Journal:  Int J Mol Sci       Date:  2019-08-30       Impact factor: 5.923

Review 5.  Wnt/β-catenin signaling in cancers and targeted therapies.

Authors:  Fanyuan Yu; Changhao Yu; Feifei Li; Yanqin Zuo; Yitian Wang; Lin Yao; Chenzhou Wu; Chenglin Wang; Ling Ye
Journal:  Signal Transduct Target Ther       Date:  2021-08-30

6.  Tankyrase 1 inhibitior XAV939 increases chemosensitivity in colon cancer cell lines via inhibition of the Wnt signaling pathway.

Authors:  Xuefang Wu; Feng Luo; Jinbang Li; Xueyun Zhong; Kunping Liu
Journal:  Int J Oncol       Date:  2016-01-26       Impact factor: 5.650

7.  Signalling pathway impact analysis based on the strength of interaction between genes.

Authors:  Zhenshen Bao; Xianbin Li; Xiangzhen Zan; Liangzhong Shen; Runnian Ma; Wenbin Liu
Journal:  IET Syst Biol       Date:  2016-08       Impact factor: 1.615

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.